David Oppenheim

1.7k total citations · 1 hit paper
11 papers, 1.3k citations indexed

About

David Oppenheim is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Oppenheim has authored 11 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Oppenheim's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (5 papers). David Oppenheim is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (5 papers). David Oppenheim collaborates with scholars based in United Kingdom, Switzerland and France. David Oppenheim's co-authors include Adrian Hayday, Michael Girardi, Robert E. Tigelaar, Renata B. Filler, Carrie R. Steele, Earl J. Glusac, Julia M. Lewis, Paul Hobby, Brian J. Sutton and Scott Roberts and has published in prestigious journals such as Science, Journal of Clinical Oncology and Nature Immunology.

In The Last Decade

David Oppenheim

11 papers receiving 1.3k citations

Hit Papers

Regulation of Cutaneous Malignancy by γδ T Cells 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Oppenheim United Kingdom 9 1.1k 530 144 67 58 11 1.3k
Jean‐Paul Rivals Switzerland 12 774 0.7× 461 0.9× 186 1.3× 81 1.2× 42 0.7× 16 1.1k
Robin Handon United States 9 1.3k 1.1× 471 0.9× 194 1.3× 54 0.8× 29 0.5× 11 1.5k
Jin-Qing Liu United States 20 982 0.9× 546 1.0× 290 2.0× 91 1.4× 29 0.5× 55 1.3k
Carrie R. Steele United Kingdom 6 802 0.7× 324 0.6× 104 0.7× 49 0.7× 53 0.9× 7 918
Panu E. Kovanen Finland 8 931 0.8× 398 0.8× 142 1.0× 97 1.4× 28 0.5× 13 1.2k
F Austrup Germany 8 662 0.6× 220 0.4× 113 0.8× 46 0.7× 30 0.5× 10 909
Chun‐Jen J. Chen New Zealand 11 936 0.8× 283 0.5× 256 1.8× 75 1.1× 27 0.5× 15 1.1k
Adeline Crinier France 8 874 0.8× 293 0.6× 202 1.4× 49 0.7× 27 0.5× 10 1.1k
Sofia Mensurado Portugal 11 905 0.8× 587 1.1× 204 1.4× 41 0.6× 28 0.5× 17 1.2k
Janet Wagner United States 7 895 0.8× 251 0.5× 141 1.0× 120 1.8× 89 1.5× 9 1.1k

Countries citing papers authored by David Oppenheim

Since Specialization
Citations

This map shows the geographic impact of David Oppenheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Oppenheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Oppenheim more than expected).

Fields of papers citing papers by David Oppenheim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Oppenheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Oppenheim. The network helps show where David Oppenheim may publish in the future.

Co-authorship network of co-authors of David Oppenheim

This figure shows the co-authorship network connecting the top 25 collaborators of David Oppenheim. A scholar is included among the top collaborators of David Oppenheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Oppenheim. David Oppenheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Girardi, Michael, David Oppenheim, Carrie R. Steele, et al.. (2018). Pillars Article: Regulation of Cutaneous Malignancy by γδ T Cells. Science. 2001. 294: 605–609. The Journal of Immunology. 200(9). 3031–3035. 1 indexed citations
2.
Girardi, Michael, David Oppenheim, Carrie R. Steele, et al.. (2018). Pillars Article: Regulation of Cutaneous Malignancy by γδ T Cells. Science. 2001. 294: 605-609.. PubMed. 200(9). 3031–3035. 32 indexed citations
4.
Oppenheim, David, Roberto Spreafico, Annie Etuk, et al.. (2014). Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy. British Journal of Cancer. 110(5). 1221–1227. 22 indexed citations
5.
Delord, Jean‐Pierre, Josep Tabernero, Rocio García‐Carbonero, et al.. (2013). Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma. European Journal of Cancer. 50(3). 496–505. 22 indexed citations
7.
Oppenheim, David, Scott Roberts, Sarah L. Clarke, et al.. (2005). Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nature Immunology. 6(9). 928–937. 363 indexed citations
8.
Girardi, Michael, David Oppenheim, Earl J. Glusac, et al.. (2004). Characterizing the Protective Component of the αβ T Cell Response to Transplantable Squamous Cell Carcinoma. Journal of Investigative Dermatology. 122(3). 699–706. 31 indexed citations
9.
Girardi, Michael, David Oppenheim, Carrie R. Steele, et al.. (2001). Regulation of Cutaneous Malignancy by γδ T Cells. Science. 294(5542). 605–609. 782 indexed citations breakdown →
10.
Steele, Carrie R., David Oppenheim, & Adrian Hayday. (2000). γδ T cells: Non-classical ligands for non-classical cells. Current Biology. 10(7). R282–R285. 27 indexed citations
11.
Damiano, V.V., et al.. (1990). Intraluminal fibrosis induced unilaterally by lobar instillation of CdCl2 into the rat lung.. PubMed. 137(4). 883–94. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026